{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:22Z","timestamp":1792098442111,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.016","type":"journal-article","created":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T09:58:26Z","timestamp":1193392706000},"page":"8843-8850","source":"Crossref","is-referenced-by-count":37,"title":["Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A"],"prefix":"10.1016","volume":"25","author":[{"given":"Yun-Zhou","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2007.10.016_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxtins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.vaccine.2007.10.016_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2007.10.016_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.addr.2005.01.016","article-title":"Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology","volume":"57","author":"Middlebrook","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2007.10.016_bib4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0264-410X(99)00253-4","article-title":"Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A","volume":"18","author":"Clayton","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.016_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02255918","article-title":"DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice","volume":"7","author":"Shyu","year":"2000","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2007.10.016_bib6","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/S0264-410X(03)00260-3","article-title":"DNA vaccination protects against botulinum neurotoxin type F","volume":"21","author":"Bennett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.016_bib7","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1016\/j.vaccine.2004.04.006","article-title":"Efficacy DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters","volume":"22","author":"Jathoul","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.016_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1872-2075(07)60052-1","article-title":"High-level expression of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli and its immunogenicity as an antigen","volume":"23","author":"Yu","year":"2007","journal-title":"Chin J Biotech"},{"key":"10.1016\/j.vaccine.2007.10.016_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0264-410X(99)00271-6","article-title":"DNA and RNA-based vaccines: principles, progress and prospects","volume":"18","author":"Leitner","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.016_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000053992","article-title":"Alphavirus vectors: applications for DNA vaccines production and gene expression","volume":"43","author":"Lundstrom","year":"2000","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.016_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm813","article-title":"Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways","volume":"9","author":"Leitner","year":"2003","journal-title":"Nat Med"},{"issue":"11\/2","key":"10.1016\/j.vaccine.2007.10.016_bib12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.vaccine.2003.10.013","article-title":"Apoptosis is essential for the increased efficacy of alphavirus-based DNA vaccines","volume":"20","author":"Leitner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.016_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nbt0698-562","article-title":"Enhancing immune responses using suicidal DNA vaccines","volume":"16","author":"Berglund","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2007.10.016_bib14","first-page":"51","article-title":"Enhancement of tumor-specific immune response with plasmid DNA replicon vectors","volume":"60","author":"Leitner","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2007.10.016_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1128\/JVI.72.2.950-958.1998","article-title":"DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector","volume":"72","author":"Hariharan","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.016_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/IAI.71.1.575-579.2003","article-title":"Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A","volume":"71","author":"Kirman","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.016_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1099\/vir.0.80481-0","article-title":"Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1","volume":"86","author":"Nordstrom","year":"2005","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.016_bib18","first-page":"87","article-title":"High-level expression of foreign genes in vivo and in vitro by improved DNA-based replicon vector derived from Semliki Forest virus","volume":"33","author":"Yu","year":"2006","journal-title":"Prog Biochem Biophys"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.016_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-0813.1999.tb10314.x","article-title":"Comparative immunogenicity of two bivalent botulinum vaccines","volume":"77","author":"Brown","year":"1999","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2007.10.016_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2003.08.010","article-title":"Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice","volume":"22","author":"Xiao","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.016_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-2478(97)00171-5","article-title":"Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence","volume":"61","author":"Haddad","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2007.10.016_bib22","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1128\/JVI.73.12.10214-10223.1999","article-title":"Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response","volume":"73","author":"Lewis","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.016_bib23","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/S0264-410X(99)00171-1","article-title":"Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines","volume":"17","author":"Rice","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.016_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.016_bib25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/339677","article-title":"Immune protection against staphylococcal enterotoxin induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon","volume":"185","author":"Lee","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T16:08:48Z","timestamp":1588003728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":25,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011516"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}